Maurizio Cammalleri Selected Research

CYN 154806

11/2004

Somatostatin receptors differentially affect spontaneous epileptiform activity in mouse hippocampal slices.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Maurizio Cammalleri Research Topics

Disease

13	Hypoxia (Hypoxemia) 01/2022 - 08/2007
11	Inflammation (Inflammations) 09/2021 - 01/2016
9	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2021 - 07/2015
6	Glaucoma 01/2021 - 12/2019
5	Retinopathy of Prematurity (Retrolental Fibroplasia) 01/2022 - 01/2011
5	Retinal Neovascularization 11/2021 - 08/2007
4	Retinal Diseases 08/2021 - 06/2015
4	Gliosis 12/2020 - 01/2017
2	Disease Progression 01/2022 - 01/2017
2	Neoplasms (Cancer) 01/2022 - 01/2019
2	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2020 - 01/2019
2	Ganglion Cysts (Ganglion) 03/2018 - 01/2017
2	Pathologic Neovascularization 01/2018 - 01/2016
2	Macular Degeneration (Age-Related Maculopathy) 09/2017 - 01/2016
2	Epilepsy (Aura) 04/2008 - 11/2004
1	Hemangioma (Angioma) 01/2022
1	Reperfusion Injury 12/2021
1	Pain (Aches) 01/2021
1	Neuralgia (Stump Neuralgia) 01/2021
1	Optic Nerve Diseases (Optic Neuropathy) 12/2020
1	Ocular Hypertension (Glaucoma, Suspect) 03/2020
1	Rare Diseases (Rare Disease) 01/2020
1	Hermanski-Pudlak Syndrome (Hermansky-Pudlak Syndrome) 01/2020
1	Oculocutaneous Albinism (Albinism, Yellow Mutant) 01/2020
1	Optic Nerve Injuries 12/2019
1	Vascular Diseases (Vascular Disease) 01/2019
1	Melanoma (Melanoma, Malignant) 01/2019
1	Retinitis 01/2019
1	Fibrosis (Cirrhosis) 01/2019
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2019
1	Eye Diseases (Eye Disease) 01/2019
1	Optic Neuritis (Retrobulbar Neuritis) 10/2018
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2018
1	Multiple Sclerosis 03/2018
1	Retinal Degeneration 09/2017
1	Hyperglycemia 01/2017
1	Choroidal Neovascularization 01/2016

Drug/Important Bio-Agent (IBA)

21	Retinaldehyde (Retinal)IBA 01/2022 - 08/2007
12	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 08/2007
7	Oxygen (Dioxygen)IBA 01/2022 - 01/2011
5	Propranolol (Inderal)FDA LinkGeneric 01/2022 - 01/2011
5	Octreotide (Sandostatin)FDA LinkGeneric 01/2020 - 11/2004
4	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2022 - 01/2019
4	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2019 - 01/2016
3	Neuroprotective AgentsIBA 01/2021 - 01/2016
3	Fatty Acids (Saturated Fatty Acids)IBA 10/2018 - 09/2017
3	Transcription Factors (Transcription Factor)IBA 01/2017 - 02/2012
2	Lisosan GIBA 01/2021 - 12/2018
2	Streptozocin (Streptozotocin)FDA Link 01/2021 - 01/2017
2	AntioxidantsIBA 01/2021 - 01/2021
2	MelatoninIBA 12/2020 - 03/2020
2	Methylcellulose (BFL)IBA 12/2020 - 03/2020
2	agomelatine (S20098)IBA 12/2020 - 03/2020
2	ColforsinIBA 04/2020 - 12/2019
2	tramiprosateIBA 04/2020 - 12/2019
2	Vitamin B Complex (B Vitamins)IBA 04/2020 - 12/2019
2	Proteins (Proteins, Gene)FDA Link 01/2020 - 01/2011
2	Somatostatin (Somatotropin Release-Inhibiting Factor)IBA 01/2020 - 04/2008
2	Urokinase Plasminogen Activator ReceptorsIBA 01/2019 - 01/2017
2	Pharmaceutical PreparationsIBA 01/2019 - 01/2019
2	Peptides (Polypeptides)IBA 01/2016 - 04/2008
2	somatostatin receptor 2IBA 02/2012 - 08/2007
1	XenobioticsIBA 01/2022
1	Angiotensin IIIBA 12/2021
1	angiotensin I (1-7)IBA 12/2021
1	candesartan cilexetil (Amias)FDA Link 12/2021
1	LuteinIBA 09/2021
1	Gabapentin (Neurontin)FDA LinkGeneric 01/2021
1	SecretagoguesIBA 01/2021
1	Blood Glucose (Blood Sugar)IBA 01/2021
1	Butyric Acid (Butanoic Acid)IBA 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	Brimonidine Tartrate (Alphagan)FDA LinkGeneric 12/2020
1	Adrenergic Agonists (Adrenergic Receptor Agonist)IBA 12/2020
1	Ophthalmic Solutions (Eye Drops)IBA 12/2020
1	Timolol (Blocadren)FDA LinkGeneric 12/2020
1	Conditioned Culture MediaIBA 11/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	DysbindinIBA 01/2020
1	oxalylglycineIBA 01/2020
1	VitaminsIBA 12/2019
1	PlasminogenIBA 01/2019
1	Formyl Peptide Receptors (Formyl Peptide Receptor)IBA 01/2019
1	Liver ExtractsIBA 01/2019
1	IntegrinsIBA 01/2019
1	Fibrinolysin FDA Link 01/2019
1	oncomodulinIBA 03/2018
1	Myelin-Oligodendrocyte GlycoproteinIBA 03/2018
1	Calcium-Binding ProteinsIBA 03/2018
1	Aquaporins (Water Channels)IBA 01/2018
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2018
1	Nitric Oxide Synthase (NO Synthase)IBA 01/2018
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 09/2017
1	Complement System Proteins (Complement)IBA 09/2017
1	polyethylene glycol 400IBA 09/2017
1	beta Adrenergic ReceptorsIBA 01/2017
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2017

Therapy/Procedure

4	Therapeutics 01/2021 - 02/2012
1	Punctures 11/2020
1	Light Coagulation 01/2016